表紙:脂漏性皮膚炎市場:投与経路別、治療別、剤形別、エンドユーザー別、国別、地域別-2023-2030年の産業分析、市場規模、市場シェア、予測
市場調査レポート
商品コード
1290828

脂漏性皮膚炎市場:投与経路別、治療別、剤形別、エンドユーザー別、国別、地域別-2023-2030年の産業分析、市場規模、市場シェア、予測

Seborrheic Dermatitis Market with COVID-19 Impact Analysis, By Route Of Administration, By Treatment, By Dosage Form, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 407 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
脂漏性皮膚炎市場:投与経路別、治療別、剤形別、エンドユーザー別、国別、地域別-2023-2030年の産業分析、市場規模、市場シェア、予測
出版日: 2023年05月01日
発行: AnalystView Market Insights
ページ情報: 英文 407 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

脂漏性皮膚炎の市場規模は2022年に25億8,490万米ドルとなり、2023年から2030年にかけてCAGR 11.6%で拡大

脂漏性皮膚炎市場- 市場力学

皮膚病有病率の増加

脂漏性皮膚炎のリスクは、乾癬、湿疹、癜風を含む多くの皮膚疾患によって増加し、これが市場の収益成長を促進する要因となっています。全米湿疹協会によると、湿疹の有病率は幼児期にピークに達し、生涯のある時点で10人に1人が罹患すると考えられています。新興国市場の成長において重要な要素は、ヘルスケアコストの上昇であり、これはインフラ整備の一助となっています。資金調達を後押ししてヘルスケア・インフラを発展させるさまざまな政府機関のイニシアチブは、市場力学にさらに大きな影響を与えると思われます。

脂漏性皮膚炎市場-主要な洞察

  • 脂漏性皮膚炎パッケージング産業はヘルスケアへの投資拡大により著しい成長が予測される
  • 投与経路セグメンテーションに基づくと、2022年には局所投与剤が最大の市場シェアを示すと予測される
  • 治療法別では、抗真菌剤が2022年に最大の市場シェアを示すと予測されます。
  • 剤形別では、クリームが2022年に最大の市場シェアを示すと予測されました。
  • エンドユーザー別では、2022年には専門クリニックが主要タイプとなっています。
  • 地域別では、北米が2022年に最大の収益源となりました。

脂漏性皮膚炎市場-セグメンテーション分析:

世界の脂漏性皮膚炎市場は、投与経路、治療法、剤形、エンドユーザー、地域に基づいて細分化されます。

市場は投与経路に基づいて4つのカテゴリーに分けられる:非経口剤、局所剤、経口剤、その他局所剤が市場を独占しています。市場で入手可能な治療薬の大半は外用薬です。これらの薬剤は様々な形態があり、専門医のアドバイスに従って定期的に局所的に使用する必要があります。良好な結果をもたらす外用薬の発売が増加していることから、今後、さらに拡大する可能性があります。人気のある選択肢には、ケトコナゾール外用薬があります。この薬は約4週間かけて病気を治療します。

市場は剤形によってカテゴリーに分けられる:シャンプー、クリーム、ジェル、軟膏、その他です。CAGRが最も高かったのはクリームで、軟膏、シャンプーと続く。後者は、コンディショナーやその他の特別に処方された洗髪料があり、頻繁に使用することでフケの問題を解消することが期待できるため、フケを治療するための最も一般的なアプローチのひとつです。

脂漏性皮膚炎市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。脂漏性皮膚炎市場は北米で最も急速に拡大すると予想されるが、これは同地域で新規かつ効果的な治療法の開拓に取り組む製薬企業が増加しているためです。統計によると、カナダ人の5人に1人がフケ症に悩まされており、市販のシャンプーで対処できる可能性があります。北米の人口の半数以上がこの病気に罹患していると予想され、製品に対する大きな需要があることを示唆しています。

脂漏性皮膚炎市場-競合情勢:

脂漏性皮膚炎は、市販薬と処方薬の両方を含む、さまざまな企業のさまざまな治療法で治療することができます。F. Hoffmann-La Roche Ltd.、Pfizer Inc.、Bayer AG、Eli Lilly and Company、Abbottは、この分野で活躍している主要企業の一部です。脂漏性皮膚炎治療薬の市場は、中小の製薬会社、補完代替医療のプロバイダー、医療機器のメーカーなど、競合他社がひしめいています。脂漏性皮膚炎治療薬市場は絶えず変化しており、新しい治療薬が開発され試されるにつれて、おそらく新しい企業が市場に参入してくると思われます。

最近の動き

2022年2月、アルカティスはSTRATUM第3相試験の最終参加者が登録されたことを発表しました。この試験の目的は、ロフルミラストが脂漏性皮膚炎患者にどのような影響を与えるかを理解することです。

研究の主な特徴

  • この脂漏性皮膚炎市場に関する調査レポートは、2022年を基準年として、市場規模、CAGR、推定・予測(2023-2030年)を提供しています。
  • この調査レポートは、脂漏性皮膚炎市場に関する最新動向の洞察を顧客に提供します。
  • 調査レポートは、異なるセグメント/国にわたる潜在的な成長機会を解明し、脂漏性皮膚炎市場の魅力的な投資提案マトリクスを説明します。
  • 新規投資機会、既存企業が直面する課題、脂漏性皮膚炎市場における持続的成長要因を特定
  • 脂漏性皮膚炎市場規模、予測、CAGR、市場力学に対するCOVID-19の影響について調査範囲で詳細に考察COVID後の脂漏性皮膚炎市場に関する詳細な洞察もカバーします。
  • 本レポートのユーザーに脂漏性皮膚炎市場の包括的な見解を提供するため、脂漏性皮膚炎市場の競合情勢と主要イノベーター分析も含めています。
  • 本調査では、市場規模、成長率、魅力度に基づいてすべての業界セグメントをベンチマークする成長見通しマッピング分析を網羅しています。
  • 主要市場参入企業の詳細な企業プロファイルを掲載しており、脂漏性皮膚炎市場で事業展開する企業の財務情報や戦略的イニシアチブを理解するのに役立ちます。
  • さらに、本レポートでは、世界レベルだけでなく地域レベルで市場に関与する主要参入企業の重要な買収&合併、提携&ジョイントベンチャー、新発売、研究開発、地域展開についても明らかにしています。
  • 脂漏性皮膚炎の世界市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界の様々な利害関係者を対象としています。

目次

第1章 脂漏性皮膚炎市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 脂漏性皮膚炎の主要な市場動向

  • 脂漏性皮膚炎市場促進要因
  • 脂漏性皮膚炎市場抑制要因
  • 脂漏性皮膚炎の市場機会
  • 脂漏性皮膚炎市場の今後の動向

第4章 脂漏性皮膚炎業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 脂漏性皮膚炎市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 脂漏性皮膚炎の市場情勢

  • 脂漏性皮膚炎市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 脂漏性皮膚炎市場- 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 局所
    • 非経口
    • 経口
    • その他

第8章 脂漏性皮膚炎市場- 治療別

  • 概要
    • 治療別セグメントシェア分析
    • 硫黄製品
    • 抗炎症薬
    • 抗真菌剤
    • その他

第9章 脂漏性皮膚炎市場- 剤形別

  • 概要
    • 剤形別セグメントシェア分析
    • シャンプー
    • 軟膏
    • ジェル
    • クリーム
    • その他

第10章 脂漏性皮膚炎市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 専門クリニック
    • 病院
    • ホームケア
    • その他

第11章 脂漏性皮膚炎市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の脂漏性皮膚炎の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の脂漏性皮膚炎主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋地域の脂漏性皮膚炎の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの脂漏性皮膚炎の主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの脂漏性皮膚炎の主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 脂漏性皮膚炎業界

  • 競合ダッシュボード
  • 企業プロファイル
    • ZF Friedrichshafen AG
    • UFI Filters
    • TOYOTA BOSHOKU CORPORATION
    • Tenneco Inc.
    • Parker Hannifin
    • MANN+HUMMEL
    • MAHLE GmbH
    • Magneti Marelli
    • Holley Performance Products
    • Hitachi Automotive System Ltd.
    • Hengst SE
    • FRAM GROUP IP LLC
    • Donaldson Company Inc.
    • Cummins Filtration
    • ALCO Filters Ltd.
    • AC Delco

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Seborrheic Dermatitis Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Seborrheic Dermatitis Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Seborrheic Dermatitis Market: Treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Seborrheic Dermatitis Market, by Treatment 2018-2030 (USD Million)
  • TABLE Seborrheic Dermatitis Market: Regional snapshot (2022)
  • TABLE Seborrheic Dermatitis Market: Dosage Form Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Dosage Form
  • TABLE Global Seborrheic Dermatitis Market, by Dosage Form 2018-2030 (USD Million)
  • TABLE Seborrheic Dermatitis Market: END-USERS Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by CC
  • TABLE Global Seborrheic Dermatitis Market, by END-USERS 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Seborrheic Dermatitis Market, by Region 2018-2030 (USD Million)
  • TABLE North America Seborrheic Dermatitis Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Seborrheic Dermatitis Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Seborrheic Dermatitis Market, by Treatment, 2018-2030 (USD Million)
  • TABLE North America Seborrheic Dermatitis Market, by Dosage Form, 2018-2030 (USD Million)
  • TABLE North America Seborrheic Dermatitis Market, by END-USERS, 2018-2030 (USD Million)
  • TABLE Europe Seborrheic Dermatitis Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Seborrheic Dermatitis Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Seborrheic Dermatitis Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Europe Seborrheic Dermatitis Market, by Dosage Form, 2018-2030 (USD Million)
  • TABLE Europe Seborrheic Dermatitis Market, by END-USERS, 2018-2030 (USD Million)
  • TABLE Asia Pacific Seborrheic Dermatitis Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Seborrheic Dermatitis Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Seborrheic Dermatitis Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Seborrheic Dermatitis Market, by Dosage Form, 2018-2030 (USD Million)
  • TABLE Asia Pacific Seborrheic Dermatitis Market, by END-USERS, 2018-2030 (USD Million)
  • TABLE Latin America Seborrheic Dermatitis Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Seborrheic Dermatitis Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Seborrheic Dermatitis Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Latin America Seborrheic Dermatitis Market, by Dosage Form, 2018-2030 (USD Million)
  • TABLE Latin America Seborrheic Dermatitis Market, by END-USERS, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Seborrheic Dermatitis Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Seborrheic Dermatitis Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Seborrheic Dermatitis Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Seborrheic Dermatitis Market, by Dosage Form, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Seborrheic Dermatitis Market, by END-USERS, 2018-2030 (USD Million)

List of Figures

  • FIGURE Seborrheic Dermatitis Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Treatment segment market share analysis, 2022 & 2030
  • FIGURE Treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Dosage Form segment market share analysis, 2022 & 2030
  • FIGURE Dosage Form segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE END-USERS segment market share analysis, 2022 & 2030
  • FIGURE END-USERS segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Seborrheic Dermatitis Market share and leading players, 2022
  • FIGURE Europe Seborrheic Dermatitis Market share and leading players, 2022
  • FIGURE Asia Pacific Seborrheic Dermatitis Market share and leading players, 2022
  • FIGURE Latin America Seborrheic Dermatitis Market share and leading players, 2022
  • FIGURE Middle East and Africa Seborrheic Dermatitis Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Seborrheic Dermatitis Market share analysis by country, 2022
  • FIGURE Germany Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Seborrheic Dermatitis Market share analysis by country, 2022
  • FIGURE India Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Seborrheic Dermatitis Market share analysis by country, 2022
  • FIGURE Brazil Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Seborrheic Dermatitis Market share analysis by country, 2022
  • FIGURE Saudi Arabia Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Seborrheic Dermatitis Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1273

REPORT HIGHLIGHT

Seborrheic Dermatitis Market size was valued at USD 2,584.9 Million in 2022, expanding at a CAGR of 11.6% from 2023 to 2030.

Seborrheic dermatitis is a mild medical illness that does not seriously injure the individual who has it. It is a very prevalent, non-contagious illness that may be treated with the bare minimum of care. Itchy red spots and oily scales are signs of seborrheic dermatitis. On the scalp and other body areas, it manifests as flaky, itchy, and dry skin. Sebaceous glands are referred to as seborrheic, and skin is referred to as derm. If it appears on an adult's scalp, it is commonly referred to as dandruff. If it affects an infant, the same ailment is referred to as cradle cap.

Seborrheic Dermatitis Market- Market Dynamics

Augmented prevalence of dermatological illnesses

The risk of seborrheic dermatitis is increased by a number of skin disorders, including psoriasis, eczema, and tinea versicolor, which is the reason for fueling the market's revenue growth. According to the National Eczema Association, the prevalence of eczema peaks in early childhood and is thought to affect 1 in 10 people at some point in their lifespan. A significant element in the market's revenue growth is the rising cost of healthcare, which aids in the development of its infrastructure. The initiatives of different government bodies to develop the healthcare infrastructure by boosting financing will have an even greater influence on market dynamics.

Seborrheic Dermatitis Market- Key Insights

  • As per the analysis shared by our research analyst, the global seborrheic dermatitis packaging market is estimated to grow annually at a CAGR of around 11.1% over the forecast period (2023-2030)
  • The seborrheic dermatitis packaging industry is projected to grow at a significant rate due to the growing investment in healthcare
  • Based on Route of Administration segmentation, topical was predicted to show maximum market share in the year 2022
  • Based on treatment segmentation, antifungal was predicted to show maximum market share in the year 2022
  • Based on dosage form segmentation, creams was predicted to show maximum market share in the year 2022
  • Based on end-users segmentation, specialty clinics was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Seborrheic Dermatitis Market- Segmentation Analysis:

The Global Seborrheic Dermatitis Market is segmented on the basis of Route of Administration, Treatment, Dosage Form, End-user, and Region.

The market is divided into four categories based on Route of Administration: Parenteral, Topical, Oral, and Others The topical segment dominates the market. Considering the majority of the market-available medications used to treat the ailment are designed to be administered externally. These medications come in a variety of forms and must be used topically on a regular schedule, as advised by a medical specialist. There may be further segmental expansion as a result of the rising number of topical product releases that produce positive outcomes. Popular options include topical ketoconazole. The medication takes around 4 weeks to treat the illness.

The market is divided into categories based on dosage form: Shampoos, Creams, Gels, Ointments, and Others. The market for creams had the highest CAGR, and was followed by ointments and shampoos. The latter is among the most popular approaches to treating dandruff because there are conditioners and other specifically formulated hair-washing products that promise to eliminate the problem with frequent usage.

Seborrheic Dermatitis Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. The seborrheic dermatitis market is expected to expand the fastest in North America, due to the increasing number of pharmaceutical firms in the region dedicated to the development of novel and more effective medical therapies for the illness. According to statistics, one in every five Canadians suffers from dandruff, which may be addressed with over-the-counter shampoo. Over half of the North American population is expected to have the ailment, implying a significant demand for the product.

Seborrheic Dermatitis Market- Competitive Landscape:

Seborrheic dermatitis can be treated with a variety of treatments from different businesses, including both over-the-counter and prescription medicines. F. Hoffmann-La Roche Ltd., Pfizer Inc., Bayer AG, Eli Lilly and Company, and Abbott are a few of the major companies active in the sector. The market for seborrheic dermatitis therapies is crowded with competitors, including smaller pharmaceutical firms, providers of complementary and alternative medicine, and producers of medical equipment. The market for seborrheic dermatitis treatments is continually changing, and new companies are probably going to enter the market as novel therapies are created and put to the test.

Recent Developments:

In February 2022, Arcutis announced that the final participant in the STRATUM phase 3 trials was enrolled. The purpose of the study is to comprehend how roflumilast affects individuals with seborrheic dermatitis.

Key features of the study:

  • This proposed research study on Seborrheic Dermatitis market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Seborrheic Dermatitis market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Seborrheic Dermatitis market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Seborrheic Dermatitis market
  • Impact of COVID-19 on Seborrheic Dermatitis market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Seborrheic Dermatitis market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Seborrheic Dermatitis market, we have also included competitive landscape and key innovator analysis for the Seborrheic Dermatitis market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Seborrheic Dermatitis market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Seborrheic Dermatitis market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SEBORRHEIC DERMATITIS MARKET KEY PLAYERS

  • The Bristol Myers Squibb Company
  • Pfizer Inc.
  • Omnidermal
  • Novartis AG
  • Johnson and Johnson Services Inc.
  • GSK plc
  • Galderma
  • AstraZeneca plc
  • Arcutis Biotherapeutics
  • AbbVie Inc.

GLOBAL SEBORRHEIC DERMATITIS MARKET, BY ROUTE OF ADMINISTRATION

  • Topical
  • Parenteral
  • Oral
  • Others

GLOBAL SEBORRHEIC DERMATITIS MARKET, BY TREATMENT

  • Sulfur Products
  • Anti-Inflammatory
  • Antifungal
  • Others

GLOBAL SEBORRHEIC DERMATITIS MARKET, BY DOSAGE FORM

  • Shampoos
  • Ointments
  • Gels
  • Creams
  • Others

GLOBAL SEBORRHEIC DERMATITIS MARKET, BY END-USER

  • Specialty Clinics
  • Hospitals
  • Homecare
  • Others

GLOBAL SEBORRHEIC DERMATITIS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Seborrheic Dermatitis Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Seborrheic Dermatitis Market Snippet by Route of Administration
    • 2.1.2. Seborrheic Dermatitis Market Snippet by Treatment
    • 2.1.3. Seborrheic Dermatitis Market Snippet by Dosage Form
    • 2.1.4. Seborrheic Dermatitis Market Snippet by End-users
    • 2.1.5. Seborrheic Dermatitis Market Snippet by Country
    • 2.1.6. Seborrheic Dermatitis Market Snippet by Region
  • 2.2. Competitive Insights

3. Seborrheic Dermatitis Key Market Trends

  • 3.1. Seborrheic Dermatitis Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Seborrheic Dermatitis Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Seborrheic Dermatitis Market Opportunities
  • 3.4. Seborrheic Dermatitis Market Future Trends

4. Seborrheic Dermatitis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Seborrheic Dermatitis Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Seborrheic Dermatitis Market Landscape

  • 6.1. Seborrheic Dermatitis Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Seborrheic Dermatitis Market - By Route of Administration

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 7.1.2. Topical
    • 7.1.3. Parenteral
    • 7.1.4. Oral
    • 7.1.5. Others

8. Seborrheic Dermatitis Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
    • 8.1.2. Sulfur Products
    • 8.1.3. Anti-Inflammatory
    • 8.1.4. Antifungal
    • 8.1.5. Others

9. Seborrheic Dermatitis Market - By Dosage Form

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
    • 9.1.2. Shampoos
    • 9.1.3. Ointments
    • 9.1.4. Gels
    • 9.1.5. Creams
    • 9.1.6. Others

10. Seborrheic Dermatitis Market - By End-users

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-users, 2022 & 2030 (%)
    • 10.1.2. Specialty Clinics
    • 10.1.3. Hospitals
    • 10.1.4. Homecare
    • 10.1.5. Others

11. Seborrheic Dermatitis Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Seborrheic Dermatitis Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Seborrheic Dermatitis Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Seborrheic Dermatitis Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Seborrheic Dermatitis Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Seborrheic Dermatitis Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By END-USERS, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Dosage Form, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-users, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Seborrheic Dermatitis Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. ZF Friedrichshafen AG
    • 12.2.2. UFI Filters
    • 12.2.3. TOYOTA BOSHOKU CORPORATION
    • 12.2.4. Tenneco Inc.
    • 12.2.5. Parker Hannifin
    • 12.2.6. MANN+HUMMEL
    • 12.2.7. MAHLE GmbH
    • 12.2.8. Magneti Marelli
    • 12.2.9. Holley Performance Products
    • 12.2.10. Hitachi Automotive System Ltd.
    • 12.2.11. Hengst SE
    • 12.2.12. FRAM GROUP IP LLC
    • 12.2.13. Donaldson Company Inc.
    • 12.2.14. Cummins Filtration
    • 12.2.15. ALCO Filters Ltd.
    • 12.2.16. AC Delco

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us